FDA to Go Straight

Finally, finally the FDA has announced that it will stop the most blatant of the conflict of interest problems that has so discredited its operations. This comes only after severe pressure from Congress caused by a public ever more disgruntled by Big Pharma’s open control of the FDA.

Under the new guidelines, any scientist or physician who has $50,000 or more in financial ties to a company over the past 12 months, including stock or consulting arrangements, would be barred from panels evaluating that company’s products. Those who have received less than $50,000 in the previous year might be allowed to participate in the discussion but could not vote.

No date was actually announced for this to happen!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: